Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Makers Laboratories Ltd.

NSE: MAKERSL | BSE:506919

₹140.35 5.15 (3.81%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

128.20

Today’s High

141.00

52W low

98.00

52W High

157.00

Open Price

136.00

Prev. Close

119.7500

Volume

11425.00

Value

1603498.75

Fundamentals

Market Cap

82.80

Price to Earnings

-13.20

Price to Book Value

0.80

Dividend Yield

0.00

PE to Growth

0.40

Op Revenue TTM

104.39

Net Profit TTM

-6.26

Cash From Operating Activity

0.84

Return on Equity %

-9.93

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

135.6

10Day EMA

134.3

12Day EMA

133.9

20Day EMA

133

26Day EMA

132.7

50Day EMA

132.3

100Day EMA

130.9

200Day EMA

127.8

5Day SMA

135

10Day SMA

134.6

20Day SMA

131.8

30Day SMA

129.9

50Day SMA

134.1

100Day SMA

130.8

150Day SMA

131.2

200Day SMA

125.8

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

66.3

Week

83.1

Month

69.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

136.52

PIVOT

First Resistance

144.83

Second Resistance

149.32

Third Resistance

157.63

First Support

132.03

Second Support

123.72

Third Support

119.23

Relative Strength Index

58.44

Money Flow Index

78.62

MACD

1.24

MACD Signal

0.53

Average True Range

8.04

Average Directional Index

23.12

Rate of Change (21)

14.62

Rate of Change (125)

-3.84

Commodity Channel Index

79.4

Williams %R

-27.4

BETA

1 Month

0.75

3 Month

0.56

1 Year

0.5

3 Year

0.38

PRICE CHANGE ANALYSIS

↑ 8.8%

1 Week

Low

High

128.2

141

↑ 17.2%

1 Month

Low

High

119

145.05

↑ 11.39%

3 Months

Low

High

114

155

↓ -3.44%

6 Months

Low

High

108.4

155

↑ 15.66%

1 Year

Low

High

98.05

157

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 11.60 11.29 15.62 11.73 11.02 10.76 12.10 9.80 9.11 13.55 15.73
Operating Expenses Qtr 11.59 12.28 15.64 13.33 11.02 12.47 12.00 11.19 10.06 12.08 13.60
Operating Profit Qtr -0.14 -1.12 -0.72 -1.79 -0.18 -1.85 -0.59 -1.52 -1.03 1.42 1.47
EBIDT Qtr Cr 0.01 -0.99 -0.03 -1.60 0.00 -1.71 0.10 -1.39 -0.95 1.46 2.13
Depreciation Qtr 0.68 0.68 0.68 0.67 0.66 0.66 0.60 0.48 0.47 0.47 0.50
Net Profit Qtr -1.56 -1.95 -0.99 -2.46 -0.80 -2.57 -0.71 -2.27 -1.60 0.67 0.81
Basic EPS Qtr -2.64 -3.30 -1.68 -4.17 -1.29 -4.25 -1.07 -3.97 -3.26 1.36 1.58
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 50.24 43.68 53.26 44.83 51.62
Operating Expenses Annual Cr 52.85 46.68 49.36 41.11 48.68
Operating Profit Annual -3.76 -4.13 3.05 3.30 2.71
Operating Profit Margin Annual % -7.49 -9.46 5.72 7.35 5.26
Total Expenses Annual Cr 57.20 50.46 52.94 46.90 51.37
EBIDT Annual Cr -2.61 -3.00 3.90 3.71 2.94
EBIDT Annual margin % -5.19 -6.86 7.31 8.28 5.69
Depreciation 2.71 2.40 1.91 4.20 1.99
PAT Before ExtraOrdinary Items Annual Cr -6.95 -6.36 0.17 -1.62 -0.12
Net Profit Annual -6.95 -6.36 0.17 -1.62 -0.12
Basic EPS Annual -11.78 -10.58 0.35 -3.29 -0.25
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 51.45 58.28 50.30 49.62 44.62
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 8.96 5.59 5.48 8.43 9.90
Total Current Liabilities Annual Cr 25.73 20.91 29.71 21.07 19.36
Total Capital Plus Liabilities Annual Cr 86.15 84.79 85.48 79.12 73.88
Fixed Assets Annual 39.88 40.49 38.88 30.71 33.57
Total Non Current Assets Annual 65.30 65.63 64.13 55.92 50.11
Total Current Assets Annual 20.85 19.16 21.35 23.20 23.77
Total Assets Annual 86.15 84.79 85.48 79.12 73.88
Contingent Liabilities plus Commitments Annual Cr - 2.23 3.46 1.45 2.08
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual -3.06 -1.42 6.80 0.67 4.23
Cash from Investing Activity Annual -2.04 -3.55 -8.78 -2.65 -8.43
Cash from Financing Annual Activity 5.12 4.94 1.77 1.37 2.91
Net Cash Flow Annual - -0.04 -0.21 -0.61 -1.29
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 87.19 98.78 102.30 100.92 90.74
ROE Annual % -13.51 -10.91 0.34 -3.25 -0.27
ROCE Annual % -8.81 -8.44 3.56 -0.83 1.74
Total Debt to Total Equity Annual 0.26 0.16 0.34 0.28 0.19
EBDIT Annual Margin % -5.31 -7.04 7.43 8.35 5.71
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 28.24 26.88 25.47 25.25 29.57 20.14 27.38 26.46 27.94 30.84 34.14
Operating Expenses Qtr 26.95 26.31 24.86 25.14 27.67 20.05 24.88 25.43 25.25 24.93 27.66
Operating Profit Qtr 0.86 0.20 0.20 -0.13 1.78 -0.17 1.62 0.02 2.04 4.55 5.91
EBIDT Qtr Cr 1.29 0.57 0.61 0.12 1.90 0.09 2.51 1.02 2.66 5.92 6.52
Depreciation Qtr 1.15 1.16 1.13 1.11 1.13 1.19 1.03 0.89 0.99 1.01 1.03
Net Profit Qtr -1.29 -1.54 -1.34 -2.10 -0.28 -2.21 -0.64 -1.62 -0.61 2.03 1.74
Basic EPS Qtr -2.18 -2.61 -2.27 -3.55 -0.43 -3.65 -1.00 -2.82 -1.24 4.13 3.54
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 105.92 103.55 129.81 69.60
Operating Expenses Annual Cr 103.34 98.03 108.37 60.53
Operating Profit Annual 1.05 3.25 18.26 8.11
Operating Profit Margin Annual % 0.99 3.14 14.06 11.65
Total Expenses Annual Cr 109.83 104.39 114.13 66.89
EBIDT Annual Cr 2.58 5.52 21.44 9.07
EBIDT Annual margin % 2.44 5.33 16.51 13.03
Depreciation 4.54 4.24 4.02 4.61
PAT Before ExtraOrdinary Items Annual Cr -4.81 -2.19 11.72 1.35
Net Profit Annual -6.26 -4.75 4.98 -0.33
Basic EPS Annual -10.62 -7.90 10.12 2.74
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 63.05 69.20 59.58 54.13
Minority Interest Liability Annual Cr 41.29 40.47 38.51 32.44
Total Non Current Liabilities Annual Cr 19.75 15.08 13.23 16.50
Total Current Liabilities Annual Cr 37.17 27.54 33.01 33.12
Total Capital Plus Liabilities Annual Cr 161.26 152.29 144.33 136.19
Fixed Assets Annual 86.88 85.01 77.68 71.55
Total Non Current Assets Annual 91.45 88.96 81.42 75.15
Total Current Assets Annual 69.80 63.34 62.91 61.04
Total Assets Annual 161.26 152.29 144.33 136.19
Contingent Liabilities plus Commitments Annual Cr - 8.81 8.10 3.96
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual 0.84 -8.62 8.50 0.00
Cash from Investing Activity Annual -6.89 1.25 -11.79 0.00
Cash from Financing Annual Activity 5.74 5.78 0.33 0.00
Net Cash Flow Annual - -1.59 -2.96 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 176.83 185.88 199.50 176.07
ROE Annual % -9.93 -6.86 8.35 -0.60
ROCE Annual % -1.58 1.02 15.64 4.32
Total Debt to Total Equity Annual 0.28 0.17 0.29 0.26
EBDIT Annual Margin % 2.47 5.45 16.92 13.20
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Premchand Godha 2.15 74793307 0 0
Prashant Godha 2.08 74793308 0 0
Nirmal Gigalal Jain 1.62 74793309 0 0
Usha Premchand Godha 0.97 74793310 0 0
Bhawna Godha 0.72 74793311 0 0
Usha M Chandurkar 0.69 74793312 0 0
Kaygee Investments Private Limited 17.38 74793315 0 0
Paschim Chemicals Pvt Ltd 16.38 74793316 0 0
Kaygee Laboratories Private Limited 14.35 74793317 0 0
Mexin Medicaments Private Limited 3.12 74793318 0 0
Chandurkar Investments Private Limited 1.43 74793319 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
Tanvi Jignesh Mehta 1.25 74793337
Achyutkumar Ratilal Modi 1.07 74793338
HUF 1.68 74793324
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Aug 01, 2019 1 FINAL - Equity Share
Jul 26, 2018 1 FINAL - Equity Share
Jul 20, 2017 1 FINAL - Equity Share
Aug 02, 2016 1 FINAL - Equity Share
Jul 28, 2015 1 FINAL - Equity Share
Jul 29, 2011 1 FINAL - Equity Share
Aug 17, 2010 1 FINAL - Equity Share
Aug 07, 2002 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 23, 2024 Audited Results -
Feb 13, 2024 Quarterly Results -
Nov 07, 2023 Quarterly Results -
Aug 14, 2023 Quarterly Results -
May 22, 2023 Audited Results -
Feb 13, 2023 Quarterly Results -
Nov 14, 2022 Quarterly Results -
Aug 12, 2022 Quarterly Results -
May 27, 2022 Audited Results -
May 06, 2022 Rights issue -
Feb 09, 2022 Quarterly Results -
Nov 10, 2021 Quarterly Results & Right issue -
Aug 13, 2021 Quarterly Results -
Jun 10, 2021 Audited Results -
Feb 10, 2021 Quarterly Results -
Nov 04, 2020 Quarterly Results -
Aug 12, 2020 Quarterly Results -
Jun 15, 2020 Audited Results -
Feb 06, 2020 Quarterly Results -
Nov 06, 2019 Quarterly Results -
Aug 08, 2019 Quarterly Results -
May 22, 2019 Audited Results & Final Dividend -
Feb 13, 2019 Quarterly Results -
Nov 13, 2018 Quarterly Results -
Aug 02, 2018 Quarterly Results -
May 23, 2018 Audited Results & Dividend -
Jan 29, 2018 Quarterly Results -
Nov 14, 2017 Quarterly Results -
Aug 10, 2017 Quarterly Results -
May 11, 2017 Audited Results & Dividend -
Feb 03, 2017 Quarterly Results -
Nov 14, 2016 Quarterly Results -
Aug 09, 2016 Quarterly Results -
May 27, 2016 Audited Results & Dividend -
Apr 12, 2016 Others To sell and transfer the leasehold right of the Company in respect of the plot of said manufacturing unit consisting of land admeasuring 750 sq meters.
Feb 19, 2016 Others inter alia, to consider the sale, transfer and disposal of the Companys manufacturing unit situated at MIDC, Dombivli, District - Thane (Maharashtra) under section 180(1)(a) of the Companies Act,
Feb 02, 2016 Quarterly Results -
Nov 06, 2015 Quarterly Results -
Aug 04, 2015 Quarterly Results -
May 29, 2015 Audited Results & Dividend -
Jan 30, 2015 Quarterly Results -
Nov 12, 2014 Quarterly Results -
Jul 28, 2014 Quarterly Results -
May 27, 2014 Audited Results -
Feb 04, 2014 Quarterly Results -
Nov 13, 2013 Quarterly Results -
Aug 02, 2013 Quarterly Results -
May 29, 2013 Audited Results -
Jan 31, 2013 Quarterly Results -
Oct 29, 2012 Quarterly Results -
Aug 02, 2012 Quarterly Results -
May 30, 2012 Audited Results -
Feb 02, 2012 Quarterly Results -
Oct 21, 2011 Quarterly Results -
Aug 10, 2011 Quarterly Results -
May 20, 2011 Audited Results & Dividend -
Apr 22, 2011 Scheme of Amalgamation For approving the Scheme of Amalgamation of Harleystreet harmaceuticals Ltd. with the Company & to fix the record date for the same members entitlement of the Company shares in the ratio of 6:10.
Jan 31, 2011 Quarterly Results -
Oct 28, 2010 Quarterly Results -
Aug 12, 2010 Quarterly Results & Amalgamation The Board has approved the Amalgamation of Harleystreet Pharmaceuticals Ltd. with Company w.e.f April 01, 2010 in the ratio of 6 Equity Shares of MLL for every 10 Equity Shares of HPL.
May 31, 2010 Audited Results & Dividend -
Jan 29, 2010 Quarterly Results -
Oct 30, 2009 Quarterly Results -
Jul 29, 2009 Quarterly Results -
Jun 16, 2009 Audited Results -
Jan 30, 2009 Quarterly Results -
Oct 31, 2008 Quarterly Results -
Jul 31, 2008 Quarterly Results -
Jun 18, 2008 Audited Results -
Jan 31, 2008 Quarterly Results -
Oct 26, 2007 Quarterly Results -
Jul 30, 2007 Quarterly Results -
Jun 15, 2007 Audited Results -
May 11, 2007 Shifting of Registered Office inter alia, to consider sale of the Company's formulations manufacturing unit situated at Palghar (District Thane) and shifting of the Company's Registered Office from Palghar to Mumbai.
Mar 29, 2007 Others To close down the operations of the Company's formulations manufacturing unit situated at Palghar, (District Thane) under the provisions of Section 25FFA of Industrial Disputes Act, 1947.
Jan 31, 2007 Quarterly Results -
Oct 30, 2006 Quarterly Results -
Jul 25, 2006 Quarterly Results -
Jun 12, 2006 Accounts -
Jan 23, 2006 Quarterly Results -
Oct 28, 2005 Quarterly Results -
Jul 29, 2005 Quarterly Results -
Jun 24, 2005 Accounts -
Jan 31, 2005 Quarterly Results -
Oct 29, 2004 Quarterly Results -
Aug 30, 2004 Others Resignation of Mr. R.K.P. Verma as the Managing Director and also as the Director of the Company w.e.f. 31-08-2004.
Jul 29, 2004 Quarterly Results -
Jun 18, 2004 Accounts -
Jan 29, 2004 Quarterly Results -
Oct 30, 2003 Quarterly Results -
Jul 31, 2003 Quarterly Results (Revised)
Jun 30, 2003 Accounts -
Jan 30, 2003 Quarterly Results -
Oct 31, 2002 Quarterly Results & Half Yearly Results -
Jun 14, 2002 Accounts -
Jan 29, 2002 Quarterly Results -
Oct 31, 2001 Quarterly Results -
Jul 27, 2001 Quarterly Results -
May 15, 2001 Accounts -
Jan 25, 2001 Quarterly Results -
Oct 19, 2000 Quarterly Results -
Jun 22, 2000 Accounts -
Mar 24, 2000 Interim Dividend (Revised) -
Mar 23, 2000 Interim Dividend -
Jan 31, 2000 Quarterly Results -
Oct 27, 1999 Quarterly Results -
Oct 11, 1999 Rights Issue -
Jul 28, 1999 Quarterly Results -
May 20, 1999 Accounts & Dividend -
Jan 25, 1999 Quarterly Results -
Oct 28, 1998 Quarterly Results -
Jun 25, 1998 Accounts & Dividend -
Nov 19, 1997 Half Yearly Results. -
May 20, 1997 Accounts & Dividend. -
Jan 09, 1997 Rights Issue. -
Ex-Date Bonus Ratio Record Date
Bigul
04 Jul 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copy of Newspaper Publication
Bigul
21 Jun 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Closure of Trading Window

 Closure of Trading Window
Bigul
28 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Secretarial Compliance Report for the year ended 31st March 2024
Bigul
25 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copy of Newspaper Publication
Bigul
23 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Proposed Sale Of Land And Office Building

 Proposed sale of land and office building
Bigul
23 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Appointment of Company Secretary and Compliance Officer

 Appointment of Mr. Piyush Ajmera as Company Secretary
Bigul
23 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Audited Standalone And Consolidated Financial Results

 Audited Standalone and Consolidated Financial Results for FY24
Bigul
23 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Board Meeting Outcome for Outcome Of Board Meeting

 Outcome of Board Meeting
Bigul
07 May 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Board Meeting Intimation for Standalone And Consolidated Audited Financial Results For The 4Th Quarter And Financial Year Ended 31St March 2024

 MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 ,inter alia, to consider and approve Standalone and Consolidated Audited Financial Results for the 4th quarter and financial year ended 31st March 2024
Bigul
30 Apr 2024

MAKERS LABORATORIES LTD.-$ - 506919 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of Duplicate Share Certificate
See all News

FAQs

The latest market price of Makers Laboratories Ltd. on NSE was Rs. 140.35 as of today.

The opening share price of Makers Laboratories Ltd. was Rs. 136.00 as of today.

The 52-week high share price of Makers Laboratories Ltd. was Rs. 157.00.

The 52 week low share price of Makers Laboratories Ltd. was Rs. 98.00.

Please find Corporate actions section for more details.

The PE ratio of Makers Laboratories Ltd. is 0.40. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Makers Laboratories Ltd. was on 2019-08-01 for Rs. 1 per share. According to today’s share price, the dividend yield of Makers Laboratories Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Makers Laboratories Ltd..

Close

Let's Open Free Demat Account